In what seems a replay of concerns about technetium shortages from the 2010s, a bipartisan group of members of the U.S. House Energy & Commerce Committee has called for a study of the availability of medical isotopes for U.S. citizens.
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Allurion Technologies, Angiodynamics, Biosig Technologies, Guided Therapeutics, Quest Diagnostics, Rhine Pharma, Shifamed, Teal Health, Telix, Tioga.
Cellbion Co. Ltd. debuted on the tech-heavy Kosdaq board of the Korea Exchange Oct. 16, with share prices closing upward at ₩20,650 (US$14.94) – outdoing its initial price of ₩15,000 per share for 1.9 million shares.
Nanocube Health Ltd. is developing accessible, low-cost nanorobots that could revolutionize diagnosis and treatment of hard-to-diagnose cancers, with pancreatic cancer being the initial focus.
Preliminary results from a trial demonstrated that Science Corp.’s Prima retina implant restored ‘form vision,’ including the ability to read in patients with vision loss. Originally developed at Stanford University and then advanced by Pixium Vision SA, Prima received U.S. FDA breakthrough device designation in April 2023.
The U.K.'s Medicines and Health Care Products Regulatory Agency posted a series of draft new regulations that will increase the requirements for device makers doing business in the U.K.
New hires and promotions in the med-tech industry, including: Accuray, Axxess, Catalyst Orthoscience, Gradient Denervation Technologies, Grail, Know Labs.
RSS
